Phortas at RAPS Euro Convergence 2026
- 1 day ago
- 1 min read
Phortas will be present at the RAPS Euro Convergence 2026, taking place from 5 to 8 May in Lisbon, Portugal.
This year’s programme brings together regulators, industry experts, and thought leaders to discuss the evolving landscape of regulatory affairs across key areas of drug development and lifecycle management.
Phortas founder Jasmina Savic will be attending, and Dr. Darius Jean-Namdjou - Director, Senior RA Lead, will be contributing as a speaker in the session on Advanced therapy medicinal products (ATMPs), challenges of their regulatory pathways and their global potential in rare diseases.
On 7 May, Phortas will also be actively contributing through the organization and moderation of three sessions:
Variations 1 Year In
Conditional Approval and Expedited Pathways: EU and US Regulatory Strategies
Advanced therapy medicinal products (ATMPs), challenges of their regulatory pathways and their global potential in rare diseases
These sessions reflect ongoing work behind the scenes, engaging with regulators and industry stakeholders to shape discussions that are both practical and forward-looking.
If you are attending the conference, we welcome the opportunity to connect and exchange perspectives.
Comments